Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Curto

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|August 21, 2015
Personalized medicine and economic evaluation in oncology: all theory and no practice?Livio Garattini, Alessandro Curto, Nick Freemantle
Health Policy (Amsterdam, Netherlands)|November 13, 2012
Regional HTA in Italy: promising or confusing?Livio Garattini, Katelijne van de Vooren, Alessandro Curto
Expert Review of Pharmacoeconomics & Outcomes Research|March 6, 2015
Long-term modeling on HPV vaccination: do we really need any more?Livio Garattini, Alessandro Curto, Katelijne van de Vooren
Health Policy (Amsterdam, Netherlands)|December 20, 2014
Cost-effectiveness of trastuzumab in metastatic breast cancer: mainly a matter of price in the EU?Livio Garattini, Katelijne van de Vooren, Alessandro Curto
Pharmacoeconomics|November 30, 2013
Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studiesKatelijne van de Vooren, Silvy Duranti, Alessandro Curto, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 15, 2014
Vaccination planning and vaccine prices in a decentralizing country - ItalyAlessandro Curto, Silvy Duranti, Katelijne Van de Vooren, et al.
Applied Health Economics and Health Policy|October 26, 2013
A critical systematic review of budget impact analyses on drugs in the EU countriesKatelijne van de Vooren, Silvy Duranti, Alessandro Curto, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Pharmacoeconomics & Outcomes Research|August 21, 2015
Personalized medicine and economic evaluation in oncology: all theory and no practice?Livio Garattini, Alessandro Curto, Nick Freemantle
Health Policy (Amsterdam, Netherlands)|November 13, 2012
Regional HTA in Italy: promising or confusing?Livio Garattini, Katelijne van de Vooren, Alessandro Curto
Expert Review of Pharmacoeconomics & Outcomes Research|March 6, 2015
Long-term modeling on HPV vaccination: do we really need any more?Livio Garattini, Alessandro Curto, Katelijne van de Vooren
Health Policy (Amsterdam, Netherlands)|December 20, 2014
Cost-effectiveness of trastuzumab in metastatic breast cancer: mainly a matter of price in the EU?Livio Garattini, Katelijne van de Vooren, Alessandro Curto
Pharmacoeconomics|November 30, 2013
Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studiesKatelijne van de Vooren, Silvy Duranti, Alessandro Curto, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|March 15, 2014
Vaccination planning and vaccine prices in a decentralizing country - ItalyAlessandro Curto, Silvy Duranti, Katelijne Van de Vooren, et al.
Applied Health Economics and Health Policy|October 26, 2013
A critical systematic review of budget impact analyses on drugs in the EU countriesKatelijne van de Vooren, Silvy Duranti, Alessandro Curto, et al.
Pageof 1